David M. Haddleton
Founder at Warwick Effect Polymers Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Nigel Davis | M | - |
Medherant Ltd.
 Medherant Ltd. Pharmaceuticals: MajorHealth Technology Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom. | 9 years |
| Richard Michael John Palmer | M | - |
Warwick Effect Polymers Ltd.
 Warwick Effect Polymers Ltd. Chemicals: Major DiversifiedProcess Industries Warwick Effect Polymers is engaged in the development and manufacture of novel, high value, and functional polymers using proprietary technologies. The Company was founded in 2001 as a spin-out from the University of Warwick. Its Living Radical Polymerization (LRP) allows precise control over the production of a wide range of complex polymers and has broad applicability in the production of novel specialized polymers for the Pharmaceutical, Biotechnology and Specialty Material industries. WEP's activities are focused in two main business areas: Biopolymers and Specialty Polymers.
University of Warwick
| - |
| Keith Bedell-Pearce | M | 78 |
University of Warwick
| - |
| Abhir Hari Bhalerao | M | 60 |
University of Warwick
| 26 years |
| Ilan Kremer | M | 57 |
University of Warwick
| 12 years |
| Shervanthi Homer-Vanniasinkam | M | 65 |
University of Warwick
| - |
| Baroness Ashton | F | 68 |
University of Warwick
| - |
| Wolfgang Epple | M | - |
University of Warwick
| - |
| Quentin Mark Compton-Bishop | M | 68 |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom. | - |
| Gerard Lyons | M | 63 |
University of Warwick
| - |
| Jonnie Turpie | M | - |
University of Warwick
| - |
| Mohamed Foysol Chowdhury | M | - |
University of Warwick
| - |
| Andrew Palmer | M | 61 |
University of Warwick
| 9 years |
| Robert A. Dover | M | 79 |
University of Warwick
| - |
| Joan MacNaughton | F | 74 |
University of Warwick
| - |
| Robert Skidelsky | M | 85 |
University of Warwick
| 34 years |
| William John Edward Burt | M | 56 |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom. | 5 years |
| Jill Ogden | M | - |
Warwick Effect Polymers Ltd.
Warwick Effect Polymers Ltd. Chemicals: Major DiversifiedProcess Industries Warwick Effect Polymers is engaged in the development and manufacture of novel, high value, and functional polymers using proprietary technologies. The Company was founded in 2001 as a spin-out from the University of Warwick. Its Living Radical Polymerization (LRP) allows precise control over the production of a wide range of complex polymers and has broad applicability in the production of novel specialized polymers for the Pharmaceutical, Biotechnology and Specialty Material industries. WEP's activities are focused in two main business areas: Biopolymers and Specialty Polymers. | - |
| Neil Sachdev | M | 65 |
University of Warwick
| - |
| Ravi Kant | M | 80 |
University of Warwick
| - |
| George Cox | M | 83 |
University of Warwick
| - |
| Julian Matthew Smith | M | 59 |
Warwick Effect Polymers Ltd.
Warwick Effect Polymers Ltd. Chemicals: Major DiversifiedProcess Industries Warwick Effect Polymers is engaged in the development and manufacture of novel, high value, and functional polymers using proprietary technologies. The Company was founded in 2001 as a spin-out from the University of Warwick. Its Living Radical Polymerization (LRP) allows precise control over the production of a wide range of complex polymers and has broad applicability in the production of novel specialized polymers for the Pharmaceutical, Biotechnology and Specialty Material industries. WEP's activities are focused in two main business areas: Biopolymers and Specialty Polymers. | - |
| Ken Cunningham Cunningham | M | 71 |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom. | 7 years |
| Brian Woods-Scawen | M | 77 |
University of Warwick
| - |
| Michael Penington | M | 66 |
Warwick Effect Polymers Ltd.
Warwick Effect Polymers Ltd. Chemicals: Major DiversifiedProcess Industries Warwick Effect Polymers is engaged in the development and manufacture of novel, high value, and functional polymers using proprietary technologies. The Company was founded in 2001 as a spin-out from the University of Warwick. Its Living Radical Polymerization (LRP) allows precise control over the production of a wide range of complex polymers and has broad applicability in the production of novel specialized polymers for the Pharmaceutical, Biotechnology and Specialty Material industries. WEP's activities are focused in two main business areas: Biopolymers and Specialty Polymers. | - |
| Peter T. Warry | M | 74 |
University of Warwick
| 31 years |
| Fran Crawford | M | - |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| vignesh kumaravel | M | - |
University of Warwick
| 3 years |
| Pui Ying Lo | F | 34 |
University of Warwick
| 5 years |
| Choo Ian Ong | M | 47 |
University of Warwick
| 5 years |
| Roy Chi Ping Chung | M | 71 |
University of Warwick
| 3 years |
| Xuezheng Chen | M | 45 |
University of Warwick
| 5 years |
| Moe Tufail | M | - |
University of Warwick
| 4 years |
| Amarjot Sidhu | M | - |
University of Warwick
| 5 years |
| Matthew Hodges | M | - |
University of Warwick
| 5 years |
| Pui Ho Li | M | 34 |
University of Warwick
| 5 years |
| Ross Warwick | M | - |
University of Warwick
| 4 years |
| Kwai Ching Lau | M | 50 |
University of Warwick
| 3 years |
| Eran Hasson | M | - |
University of Warwick
| 3 years |
| Matt McLoughlin | M | - |
University of Warwick
| 3 years |
| Ahmad Shahredzuan Mohamed Shariff | M | 41 |
University of Warwick
| 4 years |
| Chenxi Yu | M | 40 |
University of Warwick
| 4 years |
| Mark Sng | M | - |
University of Warwick
| 3 years |
| Timothy Sinclair | M | 60 |
University of Warwick
| 4 years |
| Alisha Kapoor | F | - |
University of Warwick
| 4 years |
| Demetri Theofanou | M | - |
University of Warwick
| 1 years |
| Trang Nguyen Xuan Huong | F | - |
University of Warwick
| 1 years |
| Nicholas V. Scheele | M | 80 |
University of Warwick
| 6 years |
| Lauren Baker Iguaz | F | - |
University of Warwick
| 4 years |
| Rukmini Bahl | F | - |
University of Warwick
| 3 years |
| Nikola Stojanow | M | - |
University of Warwick
| 1 years |
| Nicholas McCaul | M | - |
University of Warwick
| 4 years |
| Evelina Olago | F | - |
University of Warwick
| 3 years |
| Maya Caddle | F | - |
University of Warwick
| 4 years |
| Bisola Elelu | F | - |
University of Warwick
| 1 years |
| Ed Geall | M | - |
University of Warwick
| 3 years |
| EDWARD DOGHAN | M | - |
University of Warwick
| 3 years |
| Shu Yang Fan | M | 40 |
University of Warwick
| 1 years |
| Ruslan bin Abdul Ghani | M | - |
University of Warwick
| 1 years |
| Oliver Smiddy | M | - |
University of Warwick
| 3 years |
| Giorgi Tskitishvili | M | - |
University of Warwick
| 4 years |
| Jian Nan Guo | M | 49 |
University of Warwick
| 3 years |
| Leonardo Sergio D'Alessandro | M | - |
University of Warwick
| 12 years |
| Bhrigu Bali | M | - |
University of Warwick
| 3 years |
| Daisy Xu | F | - |
University of Warwick
| 1 years |
| Kasper Alsing | M | - |
University of Warwick
| 3 years |
| Wenyi Liu | F | 37 |
University of Warwick
| 1 years |
| Chi Hang Choi | M | 56 |
University of Warwick
| 1 years |
| Hok Leung Chan | M | 61 |
University of Warwick
| 2 years |
| Boris Aleksandrovich Ryabov | M | 44 |
University of Warwick
| 2 years |
| Mohamed Emir Mavani bin Abdullah | M | 60 |
University of Warwick
| 1 years |
| Elia Videtta | M | - |
University of Warwick
| 4 years |
| Benjamin May | M | - |
University of Warwick
| 4 years |
| Zai Zhong Liang | M | 40 |
University of Warwick
| 4 years |
| Monika Chadaj | F | - |
University of Warwick
| 3 years |
| Artyom Yaremchuk | M | - |
University of Warwick
| 1 years |
| Oliver Goddard | M | - |
University of Warwick
| 4 years |
| Aaron Baker | M | - |
University of Warwick
| 4 years |
| Aneri D. Patel | F | 33 |
University of Warwick
| 3 years |
| James Byrne | M | 37 |
University of Warwick
| 1 years |
| Ravi Bhatt | M | - |
University of Warwick
| 3 years |
| Seong Mok Yeoh | M | 68 |
University of Warwick
| 1 years |
| Heng Xin Zhang | M | 40 |
University of Warwick
| 1 years |
| Kwok Pun Leung | M | 42 |
University of Warwick
| 1 years |
| Aman Johal | M | - |
University of Warwick
| 3 years |
| Yi Man Liu | F | 43 |
University of Warwick
| 2 years |
| Anya Navidski | F | - |
University of Warwick
| 3 years |
| Daria Ibrulj | F | - |
University of Warwick
| 4 years |
| Jin Gui Shi | M | 50 |
University of Warwick
| 2 years |
| Anjli Shah | F | - |
University of Warwick
| 4 years |
| David Ho | M | - |
University of Warwick
| 1 years |
| Sheel Shah | M | - |
University of Warwick
| 3 years |
| Richard Morrison | M | - |
University of Warwick
| 3 years |
| Kun Yuan Goh | M | 41 |
University of Warwick
| 4 years |
| Swie Leong Yoong | M | 46 |
University of Warwick
| 2 years |
| Bobby George | M | - |
University of Warwick
| 2 years |
| Fernando Luis Castiñeiras González | M | - |
University of Warwick
| 3 years |
| Lun Wong | M | 36 |
University of Warwick
| 4 years |
| Tulsi Gupta | F | 32 |
University of Warwick
| 3 years |
| Savan Shah | M | - |
University of Warwick
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David M. Haddleton
- Personal Network
